X-linked Ehlers-Danlos syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:75497OMIM:314400Q79.6
Who is this for?
Show terms as
1Specialists8Treatment centers5Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked Ehlers-Danlos syndrome (also called X-linked EDS, or XEDS) is a rare inherited connective tissue disorder caused by changes in the AIFM1 gene on the X chromosome. Connective tissue is like the body's glue — it holds skin, joints, blood vessels, and organs together. When this tissue does not form properly, many parts of the body can be affected. The most noticeable features include very stretchy or fragile skin, joints that move beyond their normal range (hypermobility), and easy bruising. Some people also experience muscle weakness, hearing loss, and problems with the nervous system. Because it is X-linked, the condition mainly affects males, though females who carry one changed copy of the gene may have milder symptoms. There is currently no cure for X-linked EDS. Treatment focuses on managing symptoms, protecting joints, preventing injuries, and improving quality of life. A team of specialists — including geneticists, physiotherapists, and cardiologists — typically work together to support people living with this condition. Early diagnosis is important so that the right care and monitoring can begin as soon as possible.

Also known as:

Key symptoms:

Very stretchy or fragile skin that tears or bruises easilyJoints that are loose and bend further than normal (hypermobility)Chronic joint and muscle painMuscle weaknessHearing loss (sensorineural type)Fatigue and low energySlow wound healingNeurological problems such as balance difficulties or coordination issuesDelayed motor development in childhoodSoft, velvety skin texture

Clinical phenotype terms (10)— hover any for plain English
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026KRAZATI: New indication approved
FDAcompleted
Mar 2026ELREXFIO: New indication approved
FDAcompleted
Mar 2026ZYRTEC: New indication approved
FDAcompleted
Mar 2026XARELTO: New indication approved
FDAcompleted
Mar 2026XARELTO: New indication approved
FDAcompleted
Mar 2026XEOMIN: New indication approved
FDAcompleted
Mar 2026DHIVY: New indication approved
FDAcompleted
Mar 2026VYALEV: New indication approved
FDAcompleted
Mar 2026POLIVY: New indication approved
FDAcompleted
Feb 2026XEOMIN: New indication approved
FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for X-linked Ehlers-Danlos syndrome.

View clinical trials →

No actively recruiting trials found for X-linked Ehlers-Danlos syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked Ehlers-Danlos syndrome community →

Specialists

1 foundView all specialists →

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

5 resources

KANUMA

Alexion Pharmaceuticals, Inc.

KANUMA Patient Support (Alexion OneSource)

Patient Assistance
Manufacturer Program
Accepting applications

VIMIZIM

BioMarin Pharmaceutical Inc.

VIMIZIM Patient Support (BioMarin RareConnections)

Patient Assistance
Manufacturer Program
Accepting applications

POLIVY

Genentech, Inc.

POLIVY Patient Support (Genentech Access Solutions)

Patient Assistance
Manufacturer Program
Accepting applications

VYALEV

AbbVie Inc.

VYALEV Patient Support (AbbVie Patient Assistance)

Patient Assistance
Manufacturer Program
Accepting applications

ZYRTEC

Kenvue Brands LLC

Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to X-linked Ehlers-Danlos syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked Ehlers-Danlos syndromeForum →

No community posts yet. Be the first to share your experience with X-linked Ehlers-Danlos syndrome.

Start the conversation →

Latest news about X-linked Ehlers-Danlos syndrome

2 articles
NewsFDA
FDA Approves POLIVY
POLIVY (POLATUZUMAB VEDOTIN-PIIQ) received FDA approval.
NewsFDA
FDA Approves PIROXICAM
PIROXICAM (PIROXICAM) received FDA approval.
See all news about X-linked Ehlers-Danlos syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific change in the AIFM1 gene does my family have, and what does that mean for my symptoms?,What specialists should be part of my care team, and how often should I see each one?,Are there any activities or exercises I should avoid to protect my joints?,Should my female relatives be tested as potential carriers, and what does being a carrier mean for them?,What warning signs should prompt me to go to the emergency room?,Are there any clinical trials or research studies I could participate in?,What support or accommodations can I request at school or work because of my condition?

Common questions about X-linked Ehlers-Danlos syndrome

What is X-linked Ehlers-Danlos syndrome?

X-linked Ehlers-Danlos syndrome (also called X-linked EDS, or XEDS) is a rare inherited connective tissue disorder caused by changes in the AIFM1 gene on the X chromosome. Connective tissue is like the body's glue — it holds skin, joints, blood vessels, and organs together. When this tissue does not form properly, many parts of the body can be affected. The most noticeable features include very stretchy or fragile skin, joints that move beyond their normal range (hypermobility), and easy bruising. Some people also experience muscle weakness, hearing loss, and problems with the nervous system.

How is X-linked Ehlers-Danlos syndrome inherited?

X-linked Ehlers-Danlos syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat X-linked Ehlers-Danlos syndrome?

1 specialists and care centers treating X-linked Ehlers-Danlos syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for X-linked Ehlers-Danlos syndrome?

5 patient support programs are currently tracked on UniteRare for X-linked Ehlers-Danlos syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.